Please use this identifier to cite or link to this item:
https://scholarhub.balamand.edu.lb/handle/uob/5886
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Wanchoo, Rimda | en_US |
dc.contributor.author | Karam, Sabine | en_US |
dc.contributor.author | Uppal, Nupur N | en_US |
dc.contributor.author | Barta, Valerie S | en_US |
dc.contributor.author | Deray, Gilbert | en_US |
dc.contributor.author | Devoe, Craig | en_US |
dc.contributor.author | Launay-Vacher, Vincent | en_US |
dc.contributor.author | Jhaveri, Kenar D | en_US |
dc.date.accessioned | 2022-07-20T06:15:36Z | - |
dc.date.available | 2022-07-20T06:15:36Z | - |
dc.date.issued | 2017 | - |
dc.identifier.issn | 02508095 | - |
dc.identifier.uri | https://scholarhub.balamand.edu.lb/handle/uob/5886 | - |
dc.description.abstract | Cancer immunotherapy, such as anti-cytotoxic T-lymphocyte-associated protein 4 (CTLA-4) and anti-programmed death 1 (PD-1), has revolutionized the treatment of malignancies by engaging the patient's own immune system against the tumor rather than targeting the cancer directly. These therapies have demonstrated a significant benefit in the treatment of melanomas and other cancers. | en_US |
dc.language.iso | eng | en_US |
dc.publisher | National Library of Medicine | en_US |
dc.subject | Acute interstitial nephritis | en_US |
dc.subject | Ipilimumab | en_US |
dc.subject | Targeted therapies | en_US |
dc.subject | Nivolumab | en_US |
dc.subject | Onconephrology | en_US |
dc.subject | Pembrolizumab | en_US |
dc.subject | Renal failure | en_US |
dc.title | Adverse Renal Effects of Immune Checkpoint Inhibitors: A Narrative Review | en_US |
dc.type | Journal Article | en_US |
dc.identifier.doi | 10.1159/000455014 | - |
dc.identifier.pmid | 28076863 | - |
dc.identifier.scopus | 2-s2.0-85009344282 | - |
dc.identifier.url | https://api.elsevier.com/content/abstract/scopus_id/85009344282 | - |
dc.contributor.affiliation | Faculty of Medicine | en_US |
dc.description.volume | 45 | en_US |
dc.description.issue | 2 | en_US |
dc.description.startpage | 160 | en_US |
dc.description.endpage | 169 | en_US |
dc.date.catalogued | 2022-07-20 | - |
dc.description.status | Published | en_US |
dc.identifier.openURL | https://www.karger.com/Article/FullText/455014 | en_US |
dc.relation.ispartoftext | American Journal of Nephrology | en_US |
dc.description.campus | SGH campus | en_US |
Appears in Collections: | Faculty of Medicine |
SCOPUSTM
Citations
284
checked on Nov 23, 2024
Record view(s)
38
checked on Nov 23, 2024
Google ScholarTM
Check
Altmetric
Altmetric
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.